510(k) Report

FDA applicant

Empatica S.r.l.

Milan, IT9 decisions2018–20261 recall

FDA records 9 decisions for Empatica S.r.l. (Milan, IT) from 2018 to 2026: 9 510(k) clearances. Most are in product codes POS (Physiological Signal Based Seizure Monitoring…) and MWI (Monitor, Physiological, Patient (Without…). Since 2016 its 510(k)s took a median of 196 days from receipt to decision, against 219 for FDA’s reviews in the same codes and years. Its devices cite 16 predicates, 9 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Empatica S.r.l.’s devices, and how often a recall has named them.

FDA decisions per year

3in 2025

2018: 22022: 12023: 12024: 12025: 32026 (partial year): 1
2018high 3 (2025) · low 0 (2019)2026

2026 so far, outlined.

Recalls per year

1in 2023

2023: 1
2018high 1 (2023) · low 0 (2018)2026

Class I Class II/III not classified

FIG. 1 — Empatica S.r.l. by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Empatica S.r.l.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report